Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular endothelium is a specialized layer of cells that lines the interior surface of blood vessels, serving as a semi-permeable barrier between the blood and surrounding tissues [Pober & Sessa, 2007, Nat Rev Immunol]. Maintaining the integrity of this barrier and the overall blood vessel wall is essential for physiological homeostasis, including the regulation of blood flow, nutrient exchange, and immune cell trafficking [Sumpio et al., 2002, J Vasc Surg]. Endothelial dysfunction, characterized by increased permeability and a pro-inflammatory state, is a central feature in the progression of cardiovascular diseases, sepsis, and chronic inflammatory conditions [Gimbrone & García-Cardeña, 2016, Circ Res]. While 'vascular endothelium and blood vessel wall integrity' represents a complex physiological state rather than a single molecular target, it is a major focus of therapeutic intervention. Drugs targeting specific pathways within this system, such as VEGF inhibitors or Tie2 agonists, aim to stabilize the endothelial barrier and prevent pathological leakage [Ferrara & Adamis, 2016, Nat Rev Drug Discov]. Understanding the molecular components that maintain this integrity, such as VE-cadherin and the glycocalyx, is crucial for developing treatments for conditions ranging from macular degeneration to systemic inflammatory response syndrome [Reitsma et al., 2007, Pflugers Arch].
Stabilization of endothelial cell-cell junctions (e.g., VE-cadherin), inhibition of pro-permeability signaling pathways (e.g., VEGF/VEGFR2), and reduction of oxidative stress to maintain the vascular barrier and prevent pathological leakage [Ferrara & Adamis, 2016, Nat Rev Drug Discov].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelium and blood vessel wall integrity.